Loading clinical trials...
Loading clinical trials...
A Pilot Study of Post-transplant High Dose Cyclophosphamide (PTCY) as Part of Graft-Versus-Host Disease (GVHD) Prophylaxis in T-Cell Replete HLA-Mismatched Unrelated Donor (MMUD) Ablative and Reduced Intensity Hematopoietic Cell Transplantation (HCT) for Hematological Malignancies
Conditions
Interventions
Busulfan
Cyclophosphamide
+9 more
Locations
1
United States
City of Hope Medical Center
Duarte, California, United States
Start Date
May 30, 2017
Primary Completion Date
August 1, 2020
Completion Date
September 15, 2021
Last Updated
January 9, 2024
NCT03050268
NCT07216443
NCT07295951
NCT04726241
NCT05735717
NCT04065399
Lead Sponsor
City of Hope Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions